Status:
RECRUITING
GnRH Agonist for Dual Trigger in IVF and for Luteal Phase Support in FET
Lead Sponsor:
The University of Hong Kong
Conditions:
Subfertility
Eligibility:
FEMALE
18-42 years
Phase:
PHASE3
Brief Summary
The objectives of this study are to compare the efficacy of the dual trigger group vs the hCG trigger group on the live birth rate in women undergoing IVF and the efficacy of the agonist in LP group v...
Detailed Description
Trial design: A randomised, double-blinded and placebo controlled trial will be performed in IVF cycles and another randomised, double-blinded and placebo controlled trial will be performed in FET cy...
Eligibility Criteria
Inclusion
- IVF
- Inclusion criteria:
- \- Women aged \<43 years at the time of IVF treatment
- Exclusion criteria:
- Preimplantation genetic diagnosis treatment
- Use of donor oocytes or donor embryos
- Hydrosalpinx shown on pelvic scanning and not surgically treated
- Women at risk of OHSS
- FET
- Inclusion criteria:
- Women aged \<43 years at the time of IVF treatment
- Replacing early cleavage embryos or blastocysts after thawing
- FET in natural cycles
- Exclusion criteria:
- Frozen early cleavage embryos thawed and cultured to blastocysts prior to transfer as requested by the patient
- Preimplantation genetic diagnosis treatment
- Use of donor oocytes or donor embryos
- Hydrosalpinx shown on pelvic scanning and not surgically treated
Exclusion
Key Trial Info
Start Date :
September 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 30 2025
Estimated Enrollment :
784 Patients enrolled
Trial Details
Trial ID
NCT04064840
Start Date
September 1 2019
End Date
March 30 2025
Last Update
December 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Obstetrics and Gynaecology
Hong Kong, Hong Kong, China